Stock Research for edxc

edxc

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

edxc Stock Chart & Research Data

The edxc chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the edxc chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


edxc Due diligence Resources & Stock Charts

The edxc stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View edxc Detailed Price Forecast - CNN Money CNN View edxc Detailed Summary - Google Finance
Yahoo View edxc Detailed Summary - Yahoo! Finance Zacks View edxc Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View edxc Trends & Analysis - Trade-Ideas Barrons View edxc Major Holders - Barrons
NASDAQ View edxc Call Transcripts - NASDAQ Seeking View edxc Breaking News & Analysis - Seeking Alpha
Spotlight View edxc Annual Report - CompanySpotlight.com OTC Report View edxc OTC Short Report - OTCShortReport.com
TradeKing View edxc Fundamentals - TradeKing Charts View edxc SEC Filings - Bar Chart
WSJ View Historical Prices for edxc - The WSJ Morningstar View Performance/Total Return for edxc - Morningstar
MarketWatch View the Analyst Estimates for edxc - MarketWatch CNBC View the Earnings History for edxc - CNBC
StockMarketWatch View the edxc Earnings - StockMarketWatch MacroAxis View edxc Buy or Sell Recommendations - MacroAxis
Bullish View the edxc Bullish Patterns - American Bulls Short Pains View edxc Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View edxc Stock Mentions - StockTwits PennyStocks View edxc Stock Mentions - PennyStockTweets
Twitter View edxc Stock Mentions - Twitter Invest Hub View edxc Investment Forum News - Investor Hub
Yahoo View edxc Stock Mentions - Yahoo! Message Board Seeking Alpha View edxc Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for edxc - SECform4.com Insider Cow View Insider Transactions for edxc - Insider Cow
CNBC View edxc Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for edxc - OTC Markets
Yahoo View Insider Transactions for edxc - Yahoo! Finance NASDAQ View Institutional Holdings for edxc - NASDAQ


Stock Charts

FinViz View edxc Stock Insight & Charts - FinViz.com StockCharts View edxc Investment Charts - StockCharts.com
BarChart View edxc Stock Overview & Charts - BarChart Trading View View edxc User Generated Charts - Trading View




Latest Financial News for edxc


Endexx Files Form 10 Registration Statement for SEC Review
Posted on Friday March 05, 2021

CAVE CREEK, AZ, March 05, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Endexx Corporation (OTC: EDXC), a lifestyle company focused on the intersection of science, compliance, and formulation of innovative phytonutrient-based food and nutritional products, today announced that it has publicly filed its Registration Statement on Form 10 with the Securities and Exchange Commission (SEC). This is a voluntary filing that is subject to SEC review. If the Registration Statement becomes effective, it would designate Endexx as an SEC reporting company and register the class of its shares of common stock pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended (the Exchange Act). Additionally, if the Registration Statement become effective, investors, who purchased or purchase shares of the Company’s common stock through private placements, would be permitted to resell their shares into the public markets pursuant to the exemption from registration under Rule 144 of the Securities Act of 1933, as amended, subject to compliance with the Rule’s provisions. Endexx currently publishes quarterly and annual reports, which include its financial statements, and is in compliance with the OTC Markets Group’s Alternative Reporting Standards. If the Registration Statement becomes effective, Endexx would file these reports and financial statements in the form of 10-Qs and 10-Ks with the SEC, along with Current Reports on Form 8-K, in addition to complying with its other obligations under the Exchange Act. See Filing: https://sec.report/Document/0001493152-21-005346/ About Endexx Corporation Endexx Corporation, through its operating subsidiary CBD Unlimited, develops and distributes all-natural CBD products derived from cannabis sativa plant (Hemp), containing less than 0.01% THC. Its products range from oils, capsules, topicals, and pet products, all with the shared purpose of therapeutic and pain relief for humans and pets. Phyto-Bites are CBD soft chews for animal use that are formulated to promote health and support the reduction of separation anxiety, pain, and inflammation. The science behind these products involves over half a decade of clinical research in the field and lab-work to provide accuracy in dosage and delivery of optimal absorption per serving. Safe Harbor Notice This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the company’s business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company’s periodic filings with the OTC Markets Group’s and the Company’s Form 10 filed with the SEC. The company undertakes no obligation to update any forward-looking statements. Contact: For further investor and media information, contact: Endexx Corporation Todd Davis Chairman & CEO Endexx@endexx.com 480-595-6900


Endexx Corporation Announces Participation in the Benzinga Virtual Cannabis Capital Conference
Posted on Wednesday February 24, 2021

Cave Creek, AZ, Feb. 24, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Endexx Corporation (OTC PINK:EDXC) will be presenting at the Benzinga Cannabis Capital Conference taking place on February 25-26, 2021 at 1:50 pm EST/11:50 am MST. We invite our shareholders to sign up to get a free spectator pass for the event: https://events.benzinga.com/ccc-free-registration About Benzinga Cannabis Capital Conference Benzinga's virtual Cannabis Capital Conference is guaranteed to offer participants all the benefits of an immersive and robust in-person conference from any remote location. The conference will feature an interactive forum of live presentations from top CEOs, investors, and leaders in the cannabis space. Don't miss this opportunity to connect with THE cannabis movers and shakers from across the globe. For more information and/or to register for the conference please visit: https://events.benzinga.com/ccc-free-registration We look forward to seeing you there. About Endexx Corporation Endexx Corporation, through its operating division CBD Unlimited, develops and distributes all-natural CBD products derived from cannabis sativa plant (Hemp), containing less than 0.01% THC. Its products range from oils, capsules, topicals, and pet products, all with the shared purpose of therapeutic and pain relief for humans and pets. Phyto-Bites are CBD soft chews for animal use that are formulated to promote health and support the reduction of separation anxiety, pain, and inflammation. The science behind these products involves over half a decade of clinical research in the field and lab work to provide accuracy in dosage and delivery of optimal absorption per serving. Endexx Corporation Todd Davis 4805956900 endexx@endexx.com www.endexx.com


Endexx Announces Fiscal Year-End Financial Results; Year Over Year Revenues Grow 79 Percent
Posted on Tuesday January 26, 2021

Endexx launches 2021 with Accelerated Contract Revenue CAVE CREEK, AZ, Jan. 26, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Endexx Corporation (OTC: EDXC), a lifestyle company focused on the intersection of science, compliance, and formulation of innovative phytonutrient-based food and nutritional products, today announced its fiscal 2020 annual report. Endexx is pleased to report record revenue $1.97 million with growth of 78 percent year over year. The company generated its first gross profit on an annual basis in fiscal 2020. 2020 Milestones and Highlights: Joint Venture • Endexx signs contract with DJ Khaled to launch new CBD Brand and Category International Expansion · Cleared to Distribute CBD Products in Guam. · Jamaica’s CLA grants provisional licenses for Retail and Cultivation. Increased Distribution Reach · Endexx secured a Master Distribution contract with the leading distributor in North America. · Distribution contract provides access to over 1,000,000 stores in the United States. Product Innovation · Endexx launches new “Value Line” in December to reach wider audience with more accessible price point options. · Endexx creates five unique products to be sold at counter as a POP Impulse buy. · Endexx rebranded its Premium line. Acquisitions • Endexx acquired Kush Inc. (Kushwear Brands) • Endexx acquired CBD Life Brands (Nero Water) • Endexx acquired Retail Pro Associates (Ronald Cotting and Stephen Herron) “Even in light of the most challenging year ever for the company, the industry and the market, Endexx was able to survive and thrive in fiscal 2020,” stated CEO Todd Davis. Davis added, “Endexx is positioned to accelerate top line revenue growth exponentially in 2021. Covid 19 allowed us to rethink and reposition our company and its product lines to better meet the needs of its customers. We built new price point sensitive products and point of purchase impulse buy lines providing support to our sales and distribution partners. We secured the most dominant and widespread Master Distributor in the US. We then secured one of the single greatest influencers in the Music and Entertainment industry domestically and globally to both represent our products and collaborate to design a new category and market in the CBD Industry. Mr. DJ Khaled has partnered with Endexx to deliver the most exciting new wellness products in the Industry in 2021 and beyond. Adversity has brought our collective team together and has driven our focus on success and execution of our mission for years to come,” Davis concluded. www.endexx.com & www.cbdunlimited.com About Endexx Corporation Endexx Corporation, through its operating division CBD Unlimited, develops and distributes all-natural CBD products derived from cannabis sativa plant (Hemp), containing less than 0.01% THC. Its products range from oils, capsules, topicals, and pet products, all with the shared purpose of therapeutic and pain relief for humans and pets. Phyto-Bites are CBD soft chews for animal use that are formulated to promote health and support the reduction of separation anxiety, pain, and inflammation. The science behind these products involves over half a decade of clinical research in the field and lab work to provide accuracy in dosage and delivery of optimal absorption per serving. Safe Harbor Notice This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the company’s business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company’s periodic filings with the Securities and Exchange Commission. The company undertakes no obligation to update any forward-looking statements. Contact: For further investor and media information, contact: Endexx Corporation Todd Davis Chairman & CEO Endexx@endexx.com 480-595-6900


DJ Khaled Announces "Another One" with his Entrance into The CBD Lifestyle & Wellness Sector
Posted on Wednesday December 16, 2020

Music magnate, mega producer and GRAMMY® Award-winning artist DJ Khaled announces his entrance into the CBD industry. Inspired by his personal wellness journey, Khaled, in partnership with Endexx Corporation (OTC: EDXC), a leading producer and manufacturer of hemp-derived CBD wellness products, will introduce his new company and debut the first collection in 2021.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.